Logo image of SMLR

SEMLER SCIENTIFIC INC (SMLR) Stock Fundamental Analysis

NASDAQ:SMLR - Nasdaq - US81684M1045 - Common Stock - Currency: USD

45.53  -0.44 (-0.96%)

After market: 45.3502 -0.18 (-0.39%)

Fundamental Rating

5

SMLR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. SMLR scores excellent on profitability, but there are concerns on its financial health. SMLR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

SMLR had positive earnings in the past year.
SMLR had a positive operating cash flow in the past year.
In the past 5 years SMLR has always been profitable.
In the past 5 years SMLR always reported a positive cash flow from operatings.
SMLR Yearly Net Income VS EBIT VS OCF VS FCFSMLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of -10.18%, SMLR is in the better half of the industry, outperforming 61.50% of the companies in the same industry.
With a decent Return On Equity value of -18.48%, SMLR is doing good in the industry, outperforming 61.50% of the companies in the same industry.
SMLR has a better Return On Invested Capital (4.18%) than 75.94% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SMLR is significantly above the industry average of 7.89%.
The 3 year average ROIC (20.14%) for SMLR is well above the current ROIC(4.18%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -10.18%
ROE -18.48%
ROIC 4.18%
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)20.14%
ROIC(5y)28.39%
SMLR Yearly ROA, ROE, ROICSMLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

SMLR's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 25.61%, SMLR belongs to the top of the industry, outperforming 95.19% of the companies in the same industry.
SMLR's Operating Margin has improved in the last couple of years.
The Gross Margin of SMLR (90.96%) is better than 98.93% of its industry peers.
SMLR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.61%
PM (TTM) N/A
GM 90.96%
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
SMLR Yearly Profit, Operating, Gross MarginsSMLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so SMLR is creating value.
The number of shares outstanding for SMLR has been increased compared to 1 year ago.
SMLR has more shares outstanding than it did 5 years ago.
SMLR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SMLR Yearly Shares OutstandingSMLR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
SMLR Yearly Total Debt VS Total AssetsSMLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 2.74 indicates that SMLR is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.74, SMLR is doing good in the industry, outperforming 66.31% of the companies in the same industry.
The Debt to FCF ratio of SMLR is 5.75, which is a neutral value as it means it would take SMLR, 5.75 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of SMLR (5.75) is better than 79.68% of its industry peers.
A Debt/Equity ratio of 0.59 indicates that SMLR is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.59, SMLR is not doing good in the industry: 66.84% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 5.75
Altman-Z 2.74
ROIC/WACC0.46
WACC9.07%
SMLR Yearly LT Debt VS Equity VS FCFSMLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

SMLR has a Current Ratio of 0.52. This is a bad value and indicates that SMLR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of SMLR (0.52) is worse than 93.58% of its industry peers.
SMLR has a Quick Ratio of 0.52. This is a bad value and indicates that SMLR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SMLR (0.51) is worse than 93.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.51
SMLR Yearly Current Assets VS Current LiabilitesSMLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 38.28% over the past year.
SMLR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.17% yearly.
SMLR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.29%.
Measured over the past years, SMLR shows a quite strong growth in Revenue. The Revenue has been growing by 11.43% on average per year.
EPS 1Y (TTM)38.28%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%-197.44%
Revenue 1Y (TTM)-25.29%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-44.41%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-67.65%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.07%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SMLR Yearly Revenue VS EstimatesSMLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
SMLR Yearly EPS VS EstimatesSMLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.35, the valuation of SMLR can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of SMLR indicates a rather cheap valuation: SMLR is cheaper than 94.12% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. SMLR is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 25.36, which means the current valuation is very expensive for SMLR.
SMLR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SMLR is cheaper than 73.26% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SMLR to the average of the S&P500 Index (21.76), we can say SMLR is valued inline with the index average.
Industry RankSector Rank
PE 11.35
Fwd PE 25.36
SMLR Price Earnings VS Forward Price EarningsSMLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

SMLR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SMLR is cheaper than 67.91% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, SMLR is valued cheaper than 82.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF 30.4
EV/EBITDA 45.62
SMLR Per share dataSMLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

SMLR has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.47
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SMLR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SEMLER SCIENTIFIC INC

NASDAQ:SMLR (7/11/2025, 8:00:02 PM)

After market: 45.3502 -0.18 (-0.39%)

45.53

-0.44 (-0.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-04 2025-08-04
Inst Owners50.43%
Inst Owner Change0%
Ins Owners4.89%
Ins Owner Change0.32%
Market Cap627.86M
Analysts82.86
Price Target72.42 (59.06%)
Short Float %27.73%
Short Ratio2.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.35
Fwd PE 25.36
P/S 10.31
P/FCF 30.4
P/OCF 30.07
P/B 3.14
P/tB N/A
EV/EBITDA 45.62
EPS(TTM)4.01
EY8.81%
EPS(NY)1.8
Fwd EY3.94%
FCF(TTM)1.5
FCFY3.29%
OCF(TTM)1.51
OCFY3.33%
SpS4.41
BVpS14.5
TBVpS-9.13
PEG (NY)N/A
PEG (5Y)0.47
Profitability
Industry RankSector Rank
ROA -10.18%
ROE -18.48%
ROCE 4.89%
ROIC 4.18%
ROICexc 4.34%
ROICexgc N/A
OM 25.61%
PM (TTM) N/A
GM 90.96%
FCFM 33.93%
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)20.14%
ROIC(5y)28.39%
ROICexc(3y)84.34%
ROICexc(5y)123.7%
ROICexgc(3y)231.99%
ROICexgc(5y)212.29%
ROCE(3y)23.58%
ROCE(5y)33.24%
ROICexcg growth 3Y32.01%
ROICexcg growth 5Y21.37%
ROICexc growth 3Y-65.32%
ROICexc growth 5Y-45.58%
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
F-Score3
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 5.75
Debt/EBITDA 7.32
Cap/Depr 34.42%
Cap/Sales 0.37%
Interest Coverage 250
Cash Conversion 128.57%
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.51
Altman-Z 2.74
F-Score3
WACC9.07%
ROIC/WACC0.46
Cap/Depr(3y)171.05%
Cap/Depr(5y)155.18%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.73%
Profit Quality(3y)88.64%
Profit Quality(5y)91.36%
High Growth Momentum
Growth
EPS 1Y (TTM)38.28%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%-197.44%
EPS Next Y-67.65%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.29%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-44.41%
Revenue Next Year1.07%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-45.14%
EBIT growth 3Y2.48%
EBIT growth 5Y14.34%
EBIT Next Year8.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.95%
FCF growth 3Y16.95%
FCF growth 5Y17.17%
OCF growth 1Y0.36%
OCF growth 3Y14.98%
OCF growth 5Y13.91%